High-resolution 18F-FDG PET with MRI for monitoring response to treatment in rheumatoid arthritis
- 585 Downloads
KeywordsRheumatoid Arthritis Osteoarthritis Etanercept Rheumatoid Arthritis Disease Tumor Necrosis Factor Alpha
Molecular imaging can potentially provide means for monitoring response to therapy in rheumatoid arthritis (RA) early in the course of disease .Quantitative measurements of RA disease activity made in the wrist by whole-body PET scanners, however, have inadequate accuracy because of limited spatial resolution . A high-resolution PET/CT scanner for imaging extremities has been built at our institution . In conjunction with a clinical MRI scanner, high-resolution PET/MR images can be obtained for the wrist. The CT image is used for PET/MR image coregistration.
A 57-year-old female with established RA was stable until a recent clinical flare-up in the right wrist. Clinical examination revealed synovitis, swelling, and diminished range of motion. The patient also had a history of osteoarthritis (OA). An extremity 18F-FDG PET/CT scan immediately following MRI at baseline was performed on this patient. Tumor necrosis factor alpha (TNF-α) inhibitor (etanercept) therapy was then initiated as a part of the patient’s standard of care. The patient was re-scanned 5 weeks after starting treatment.
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.